[Neoadjuvant chemotherapy of sarcoma. The experiences of the German Society for Pediatric Oncology studies on osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma].
Winkler
K
K
Jürgens
H
H
Treuner
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D005860:Germany, West; D006801:Humans; D008495:Medical Oncology; D012516:Osteosarcoma / Q000188:drug therapy / Q000401:mortality; D010372:Pediatrics; D011300:Preoperative Care; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000401:mortality; D012509:Sarcoma / Q000188:drug therapy* / Q000401:mortality; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000401:mortality; D012955:Societies, Medical; D013997:Time Factors
Neoadjuvante Chemotherapie von Sarkomen. Erfahrungen bei den GPO-Studien zum Osteosarkom (COSS), Ewing-Sarkom (CESS) und Rhabdomyosarkom (CWS).